Baakman AC, t Hart E, Kay DG, Stevens J, Klaassen ES, Maelicke A, Groeneveld GJ (2016)
First in human study with a prodrug of galantamine: Improved benefit-risk ratio?
Alzheimers Dement (N Y) 2: 13

Bhattacharya S, Maelicke A, Montag D (2015)
Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice
J Alzheimers Dis 46: 123

Maelicke A, Hoeffle-Maas A, Ludwig J, Maus A, Samochocki M, Jordis U, Koepke AK (2010)
Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy
Journal of Molecular Neuroscience 40: 135